US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 9.270
  • -1.270-12.05%
Trading Apr 19 13:36 ET
286.18MMarket Cap-3383P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
105.48%67.1M
111.69%21.05M
68.53%16.14M
161.94%15.52M
99.57%14.39M
101.79%32.66M
132.90%9.95M
258.48%9.58M
5.93M
7.21M
Selling and administrative expenses
142.06%21.08M
36.54%5.58M
259.46%5.87M
170.51%5M
305.16%4.64M
253.12%8.71M
235.50%4.08M
258.90%1.63M
--1.85M
--1.14M
-General and administrative expense
142.06%21.08M
36.54%5.58M
259.46%5.87M
170.51%5M
305.16%4.64M
253.12%8.71M
235.50%4.08M
258.90%1.63M
--1.85M
--1.14M
Research and development costs
92.18%46.02M
164.04%15.48M
29.27%10.27M
158.06%10.52M
60.81%9.76M
74.58%23.95M
92.01%5.86M
258.39%7.94M
--4.08M
--6.07M
Operating profit
-105.48%-67.1M
-111.69%-21.05M
-68.53%-16.14M
-161.94%-15.52M
-99.57%-14.39M
-101.79%-32.66M
-132.90%-9.95M
-258.48%-9.58M
-5.93M
-7.21M
Net non-operating interest income expense
Other net income (expense)
350.67%6.72M
77.26%1.8M
343.24%1.67M
1,429.52%1.61M
20,562.50%1.64M
2,625.42%1.49M
1,491.78%1.02M
63.20%377K
105K
-8K
Other non- operating income (expenses)
350.67%6.72M
77.26%1.8M
343.24%1.67M
1,429.52%1.61M
20,562.50%1.64M
2,625.42%1.49M
1,491.78%1.02M
63.20%377K
--105K
---8K
Income before tax
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
-7.22M
Income tax
Net income
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
-7.22M
Net income continuous Operations
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
---5.82M
---7.22M
Minority interest income
Net income attributable to the parent company
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
-7.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
-7.22M
Basic earnings per share
63.76%-2.74
-8.75%-0.87
-34.97%-0.66
-39.75%-0.63
-3.71%-0.58
-500.86%-7.56
-137.81%-0.8
-158.73%-0.489
-0.4508
-0.5593
Diluted earnings per share
63.76%-2.74
-8.75%-0.87
-34.97%-0.66
-39.75%-0.63
-3.71%-0.58
-500.86%-7.56
-137.81%-0.8
-158.73%-0.489
-0.4508
-0.5593
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 105.48%67.1M111.69%21.05M68.53%16.14M161.94%15.52M99.57%14.39M101.79%32.66M132.90%9.95M258.48%9.58M5.93M7.21M
Selling and administrative expenses 142.06%21.08M36.54%5.58M259.46%5.87M170.51%5M305.16%4.64M253.12%8.71M235.50%4.08M258.90%1.63M--1.85M--1.14M
-General and administrative expense 142.06%21.08M36.54%5.58M259.46%5.87M170.51%5M305.16%4.64M253.12%8.71M235.50%4.08M258.90%1.63M--1.85M--1.14M
Research and development costs 92.18%46.02M164.04%15.48M29.27%10.27M158.06%10.52M60.81%9.76M74.58%23.95M92.01%5.86M258.39%7.94M--4.08M--6.07M
Operating profit -105.48%-67.1M-111.69%-21.05M-68.53%-16.14M-161.94%-15.52M-99.57%-14.39M-101.79%-32.66M-132.90%-9.95M-258.48%-9.58M-5.93M-7.21M
Net non-operating interest income expense
Other net income (expense) 350.67%6.72M77.26%1.8M343.24%1.67M1,429.52%1.61M20,562.50%1.64M2,625.42%1.49M1,491.78%1.02M63.20%377K105K-8K
Other non- operating income (expenses) 350.67%6.72M77.26%1.8M343.24%1.67M1,429.52%1.61M20,562.50%1.64M2,625.42%1.49M1,491.78%1.02M63.20%377K--105K---8K
Income before tax -93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M-7.22M
Income tax
Net income -93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M-7.22M
Net income continuous Operations -93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M---5.82M---7.22M
Minority interest income
Net income attributable to the parent company -93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M-7.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M-7.22M
Basic earnings per share 63.76%-2.74-8.75%-0.87-34.97%-0.66-39.75%-0.63-3.71%-0.58-500.86%-7.56-137.81%-0.8-158.73%-0.489-0.4508-0.5593
Diluted earnings per share 63.76%-2.74-8.75%-0.87-34.97%-0.66-39.75%-0.63-3.71%-0.58-500.86%-7.56-137.81%-0.8-158.73%-0.489-0.4508-0.5593
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg